{{Rsnum
|rsid=6051702
|Gene=C20orf194
|Chromosome=20
|position=3271278
|Orientation=plus
|GMAF=0.1818
|Gene_s=C20orf194
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 64.6 | 31.0 | 4.4
| HCB | 77.4 | 18.2 | 4.4
| JPT | 67.3 | 29.2 | 3.5
| YRI | 55.1 | 37.4 | 7.5
| ASW | 66.7 | 24.6 | 8.8
| CHB | 77.4 | 18.2 | 4.4
| CHD | 73.4 | 25.7 | 0.9
| GIH | 67.3 | 29.7 | 3.0
| LWK | 57.3 | 37.3 | 5.5
| MEX | 75.9 | 22.4 | 1.7
| MKK | 78.8 | 20.5 | 0.6
| TSI | 65.7 | 33.3 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23933495
|Title=Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients
}}

{{PMID Auto
|PMID=20977565
|Title=ITPA gene variant protects against anemia induced by pegylated interferon-alpha and ribavirin therapy for Japanese patients with chronic hepatitis C.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}